{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:04:18Z","timestamp":1787162658659,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04334-0","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:21:10Z","timestamp":1776698470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Cu-based metal-organic framework based on desloratadine and siHIF-1\u03b1 for achievement of genes\/drugs\/CDT combination therapy in hepatocellular carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Ding","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiyu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"10","key":"4334_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/j.1398-9995.2005.00911.x","volume":"60","author":"SM Reinartz","year":"2005","unstructured":"Reinartz SM, Overbeek SE, Kleinjan A, van Drunen CM, Braunstahl GJ, Hoogsteden HC, Fokkens WJ. Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients. Allergy. 2005;60(10):1301\u20137.","journal-title":"Allergy"},{"issue":"9","key":"4334_CR2","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1080\/0284186X.2020.1769185","volume":"59","author":"I Fritz","year":"2020","unstructured":"Fritz I, Wagner P, Broberg P, Einefors R, Olsson H. Desloratadine and loratadine stand out among common H(1)-antihistamines for association with improved breast cancer survival. Acta Oncol (Stockholm Sweden). 2020;59(9):1103\u20139.","journal-title":"Acta Oncol (Stockholm Sweden)"},{"issue":"4","key":"4334_CR3","doi-asserted-by":"publisher","first-page":"101029","DOI":"10.1016\/j.tranon.2021.101029","volume":"14","author":"I Fritz","year":"2021","unstructured":"Fritz I, Wagner P, Olsson H. Improved survival in several cancers with use of H(1)-antihistamines desloratadine and loratadine. Translational Oncol. 2021;14(4):101029.","journal-title":"Translational Oncol"},{"key":"4334_CR4","doi-asserted-by":"publisher","first-page":"153303382092659","DOI":"10.1177\/1533033820926591","volume":"19","author":"J Ma","year":"2020","unstructured":"Ma J, Qi J, Li S, Zhang C, Wang H, Shao L, Yuan X, Sha Q. Desloratadine, a Novel Antigrowth Reagent for Bladder Cancer. Technol Cancer Res Treat. 2020;19:1533033820926591.","journal-title":"Technol Cancer Res Treat"},{"issue":"8","key":"4334_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12032-023-02117-3","volume":"40","author":"S Vidicevic-Novakovic","year":"2023","unstructured":"Vidicevic-Novakovic S, Stanojevic Z, Tomonjic N, Karapandza K, Zekovic J, Martinovic T, Grujicic D, Ilic R, Raicevic S, Tasic J, Isakovic A. Proapoptotic and proautophagy effect of H1-receptor antagonist desloratadine in human glioblastoma cell lines. Med Oncol (Northwood Lond Engl). 2023;40(8):241.","journal-title":"Med Oncol (Northwood Lond Engl)"},{"issue":"1","key":"4334_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41392-022-01248-9","volume":"8","author":"XP Tan","year":"2023","unstructured":"Tan XP, He Y, Yang J, Wei X, Fan YL, Zhang GG, Zhu YD, Li ZQ, Liao HX, Qin DJ, Guan XY, Li B. Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression. Signal Transduct Target therapy. 2023;8(1):14.","journal-title":"Signal Transduct Target therapy"},{"key":"4334_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ebiom.2016.06.013","volume":"9","author":"AM Ellegaard","year":"2016","unstructured":"Ellegaard AM, Dehlendorff C, Vind AC, Anand A, Cederkvist L, Petersen NHT, Nylandsted J, Stenvang J, Mellemgaard A, \u00d8sterlind K, Friis S, J\u00e4\u00e4ttel\u00e4 M. Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment. EBioMedicine. 2016;9:130\u20139.","journal-title":"EBioMedicine"},{"key":"4334_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.phrs.2016.12.021","volume":"117","author":"OF Kuzu","year":"2017","unstructured":"Kuzu OF, Toprak M, Noory MA, Robertson GP. Effect of lysosomotropic molecules on cellular homeostasis. Pharmacol Res. 2017;117:177\u201384.","journal-title":"Pharmacol Res"},{"issue":"10","key":"4334_CR9","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1038\/s41401-024-01301-z","volume":"45","author":"J Lu","year":"2024","unstructured":"Lu J, Zhao XJ, Ruan Y, Liu XJ, Di X, Xu R, Wang JY, Qian MY, Jin HM, Li WJ, Shen X. Desloratadine ameliorates paclitaxel-induced peripheral neuropathy and hypersensitivity reactions in mice. Acta Pharmacol Sin. 2024;45(10):2061\u201376.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"4334_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1365-2567.2006.02326.x","volume":"117","author":"A McIlroy","year":"2006","unstructured":"McIlroy A, Caron G, Blanchard S, Fr\u00e9maux I, Duluc D, Delneste Y, Chevailler A, Jeannin P. Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced CXCL10 production by immature human dendritic cells. Immunology. 2006;117(4):507\u201316.","journal-title":"Immunology"},{"issue":"12","key":"4334_CR11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/s41419-018-1201-x","volume":"9","author":"L Deng","year":"2018","unstructured":"Deng L, Gao X, Liu B, He X, Xu J, Qiang J, Wu Q, Liu S. NMT1 inhibition modulates breast cancer progression through stress-triggered JNK pathway. Cell Death Dis. 2018;9(12):1143.","journal-title":"Cell Death Dis"},{"issue":"50","key":"4334_CR12","first-page":"e2303403","volume":"19","author":"WJ Chen","year":"2023","unstructured":"Chen WJ, Gupta D, Yang M, Yang F, Feng N, Song J, Wood MJA, Qiu L, Chen J. A Purposefully Designed pH\/GSH-Responsive MnFe-Based Metal-Organic Frameworks as Cascade Nanoreactor for Enhanced Chemo-Chemodynamic-Starvation Synergistic Therapy. Small (Weinheim an der Bergstrasse. Germany). 2023;19(50):e2303403.","journal-title":"Germany)"},{"issue":"29","key":"4334_CR13","doi-asserted-by":"publisher","first-page":"6782","DOI":"10.1039\/D3TB00706E","volume":"11","author":"S Gulati","year":"2023","unstructured":"Gulati S, Choudhury A, Mohan G, Katiyar R, Kurikkal MPM, Kumar S, Varma RS. Metal-organic frameworks (MOFs) as effectual diagnostic and therapeutic tools for cancer. J Mater Chem B. 2023;11(29):6782\u2013801.","journal-title":"J Mater Chem B"},{"key":"4334_CR14","doi-asserted-by":"publisher","first-page":"102686","DOI":"10.1016\/j.cis.2022.102686","volume":"305","author":"JE Cun","year":"2022","unstructured":"Cun JE, Fan X, Pan Q, Gao W, Luo K, He B, Pu Y. Copper-based metal-organic frameworks for biomedical applications. Adv Colloid Interface Sci. 2022;305:102686.","journal-title":"Adv Colloid Interface Sci"},{"issue":"6","key":"4334_CR15","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.1021\/acsnano.9b01665","volume":"13","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wu W, Liu J, Manghnani PN, Hu F, Ma D, Teh C, Wang B, Liu B. Cancer-Cell-Activated Photodynamic Therapy Assisted by Cu(II)-Based Metal-Organic Framework. ACS Nano. 2019;13(6):6879\u201390.","journal-title":"ACS Nano"},{"issue":"51","key":"4334_CR16","doi-asserted-by":"publisher","first-page":"21299","DOI":"10.1021\/acs.inorgchem.3c03393","volume":"62","author":"W Lu","year":"2023","unstructured":"Lu W, Lei C, Chen K, Wang Z, Liu F, Li X, Shen J, Shen Q, Gao J, Lin W, Hu Q. A Cu-Based Metal-Organic Framework Cu-Cip with Cuproptosis for Cancer Therapy and Inhibition of Cancer Cell Migration. Inorg Chem. 2023;62(51):21299\u2013308.","journal-title":"Inorg Chem"},{"key":"4334_CR17","doi-asserted-by":"publisher","unstructured":"Roma-Rodrigues C, Mendes R, Baptista PV, Fernandes AR. Targeting tumor microenvironment for cancer therapy. Int J Mol Sci. 2019;20(4):840. https:\/\/doi.org\/10.3390\/ijms20040840.","DOI":"10.3390\/ijms20040840"},{"issue":"17","key":"4334_CR18","first-page":"2100616","volume":"33","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Gong Z, Li Z, Wang J, Zhang J, Zhao Z, Zhang P, Zheng S, Miron RJ, Yuan Q, Zhang Y. Target Reprogramming Lysosomes of CD8\u2009+\u2009T Cells by a Mineralized Metal\u2013Organic. Framew Cancer Immunotherapy. 2021;33(17):2100616.","journal-title":"Framew Cancer Immunotherapy"},{"key":"4334_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.addr.2015.10.022","volume":"98","author":"Q Hu","year":"2016","unstructured":"Hu Q, Sun W, Wang C, Gu Z. Recent advances of cocktail chemotherapy by combination drug delivery systems. Adv Drug Deliv Rev. 2016;98:19\u201334.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"4334_CR20","doi-asserted-by":"publisher","first-page":"e2101971","DOI":"10.1002\/adhm.202101971","volume":"11","author":"L Zhang","year":"2022","unstructured":"Zhang L, Li CX, Wan SS, Zhang XZ. Nanocatalyst-Mediated Chemodynamic Tumor Therapy. Adv Healthc Mater. 2022;11(2):e2101971.","journal-title":"Adv Healthc Mater"},{"key":"4334_CR21","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.redox.2018.101084","volume":"25","author":"US Srinivas","year":"2019","unstructured":"Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol. 2019;25:101084.","journal-title":"Redox Biol"},{"key":"4334_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev-ento-011019-025224","volume":"65","author":"KY Zhu","year":"2020","unstructured":"Zhu KY, Palli SR. Mechanisms, Applications, and Challenges of Insect RNA Interference. Ann Rev Entomol. 2020;65:293\u2013311.","journal-title":"Ann Rev Entomol"},{"issue":"1","key":"4334_CR23","doi-asserted-by":"publisher","first-page":"17176","DOI":"10.1038\/s41598-023-44418-7","volume":"13","author":"H Liu","year":"2023","unstructured":"Liu H, Wu X, Yang T, Wang C, Huang F, Xu Y, Peng J. NARFL deficiency caused mitochondrial dysfunction in lung cancer cells by HIF-1\u03b1-DNMT1 axis. Sci Rep. 2023;13(1):17176.","journal-title":"Sci Rep"},{"issue":"2","key":"4334_CR24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/mc.23648","volume":"63","author":"D Wang","year":"2024","unstructured":"Wang D, Liu X, Li M, Ning J. HIF-1\u03b1 regulates the cell viability in radioiodine-resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2\/NF-\u03baB signaling pathway. Mol Carcinog. 2024;63(2):238\u201352.","journal-title":"Mol Carcinog"},{"issue":"24","key":"4334_CR25","doi-asserted-by":"publisher","first-page":"25419","DOI":"10.1021\/acsnano.3c08907","volume":"17","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Wang X, Zhao Y, Cheng Z, Fang D, Liu Y, Tian G, Li M, Luo Z. Nanointegrative In Situ Reprogramming of Tumor-Intrinsic Lipid Droplet Biogenesis for Low-Dose Radiation-Activated Ferroptosis Immunotherapy. ACS Nano. 2023;17(24):25419\u201338.","journal-title":"ACS Nano"},{"issue":"1","key":"4334_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s13018-023-03818-1","volume":"18","author":"J Wu","year":"2023","unstructured":"Wu J, Yu L, Liu Y, Xiao B, Ye X, Zhao H, Xi Y, Shi Z, Wang W. Hypoxia regulates adipose mesenchymal stem cells proliferation, migration, and nucleus pulposus-like differentiation by regulating endoplasmic reticulum stress via the HIF-1\u03b1 pathway. J Orthop Surg Res. 2023;18(1):339.","journal-title":"J Orthop Surg Res"},{"issue":"3","key":"4334_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ajpath.2020.11.012","volume":"191","author":"EJ Novais","year":"2021","unstructured":"Novais EJ, Choi H, Madhu V, Suyama K, Anjo SI, Manadas B, Shapiro IM, Salgado AJ, Risbud MV. Hypoxia and Hypoxia-Inducible Factor-1\u03b1 Regulate Endoplasmic Reticulum Stress in Nucleus Pulposus Cells: Implications of Endoplasmic Reticulum Stress for Extracellular Matrix Secretion. Am J Pathol. 2021;191(3):487\u2013502.","journal-title":"Am J Pathol"},{"issue":"41","key":"4334_CR28","doi-asserted-by":"publisher","first-page":"e2404784","DOI":"10.1002\/adma.202404784","volume":"36","author":"P Schneider","year":"2024","unstructured":"Schneider P, Zhang H, Simic S, Dai L, Schr\u00f6rs B, Akilli-\u00d6zt\u00fcrk \u00d6, Lin J, Durak F, Schunke J, Bolduan V, Bogaert B, Schwiertz D, Sch\u00e4fer G, Bros M, Grabbe S, Schattenberg JM, Raemdonck K, Koynov K, Diken M, Kaps L, Barz M. Multicompartment Polyion Complex Micelles Based on Triblock Polypept(o)ides Mediate Efficient siRNA Delivery to Cancer-Associated Fibroblasts for Antistromal Therapy of Hepatocellular Carcinoma. Adv Mater (Deerfield Beach Fla). 2024;36(41):e2404784.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"issue":"3","key":"4334_CR29","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.apsb.2021.09.024","volume":"12","author":"P Moharil","year":"2022","unstructured":"Moharil P, Wan Z, Pardeshi A, Li J, Huang H, Luo Z, Rathod S, Zhang Z, Chen Y, Zhang B, Fernandez CA, Sun J, Li S. Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages. Acta Pharm Sinica B. 2022;12(3):1148\u201362.","journal-title":"Acta Pharm Sinica B"},{"key":"4334_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jcis.2020.12.028","volume":"587","author":"H Tian","year":"2021","unstructured":"Tian H, Zhang M, Jin G, Jiang Y, Luan Y. Cu-MOF chemodynamic nanoplatform via modulating glutathione and H(2)O(2) in tumor microenvironment for amplified cancer therapy. J Colloid Interface Sci. 2021;587:358\u201366.","journal-title":"J Colloid Interface Sci"},{"issue":"1","key":"4334_CR31","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1080\/13880209.2023.2190773","volume":"61","author":"L Wang","year":"2023","unstructured":"Wang L, Pan Y, Liu M, Sun J, Yun L, Tu P, Wu C, Yu Z, Han Z, Li M, Guo Y, Ma Y. Wen-Shen-Tong-Luo-Zhi-Tong Decoction regulates bone-fat balance in osteoporosis by adipocyte-derived exosomes. Pharm Biol. 2023;61(1):568\u201380.","journal-title":"Pharm Biol"},{"key":"4334_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/polym13213785","volume":"13","author":"D Xia","year":"2021","unstructured":"Xia D, Wang F, Pan S, Yuan S, Liu Y, Xu Y. Redox\/pH-Responsive Biodegradable Thiol-Hyaluronic Acid\/Chitosan Charge-Reversal Nanocarriers for Triggered Drug Release. Polymers. 2021;13:21.","journal-title":"Polymers"},{"issue":"1","key":"4334_CR33","doi-asserted-by":"publisher","first-page":"102742","DOI":"10.1016\/j.jbc.2022.102742","volume":"299","author":"B Li","year":"2023","unstructured":"Li B, Yao X, Li J, Lu X, Zhang W, Duan W, Tian Y, Li D. A tumor microenvironment-activated metal-organic framework-based nanoplatform for amplified oxidative stress-induced enhanced chemotherapy. J Biol Chem. 2023;299(1):102742.","journal-title":"J Biol Chem"},{"issue":"5","key":"4334_CR34","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1039\/D2RA06457J","volume":"13","author":"MZ Iqbal","year":"2023","unstructured":"Iqbal MZ, Shaheen M, Khan MW, Siddique S, Aftab S, Wabaidur SM, Iqbal MJ. Exploring MOF-199 composites as redox-active materials for hybrid battery-supercapacitor devices. RSC Adv. 2023;13(5):2860\u201370.","journal-title":"RSC Adv"},{"key":"4334_CR35","doi-asserted-by":"publisher","first-page":"121110","DOI":"10.1016\/j.biomaterials.2021.121110","volume":"277","author":"B Niu","year":"2021","unstructured":"Niu B, Liao K, Zhou Y, Wen T, Quan G, Pan X, Wu C. Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials. 2021;277:121110.","journal-title":"Biomaterials"},{"issue":"10","key":"4334_CR36","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1039\/D0CS00718H","volume":"50","author":"Y Xiong","year":"2021","unstructured":"Xiong Y, Xiao C, Li Z, Yang X. Engineering nanomedicine for glutathione depletion-augmented cancer therapy. Chem Soc Rev. 2021;50(10):6013\u201341.","journal-title":"Chem Soc Rev"},{"issue":"7","key":"4334_CR37","first-page":"1483","volume":"13","author":"F Wu","year":"2020","unstructured":"Wu F, Tong DD, Ni L, Wang LM, Wang MC. HIF-1\u03b1 suppresses myeloma progression by targeting Mcl-1. Int J Clin Exp Pathol. 2020;13(7):1483\u201391.","journal-title":"Int J Clin Exp Pathol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04334-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04334-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04334-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:05:53Z","timestamp":1780391153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04334-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4334"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04334-0","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments were sanctioned by the Experimental Animal Ethics Committee of Yangzhou University (No. 202408036).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"530"}}